Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Revvity Inc. (RVTY) trades at a P/B ratio of 2.4×. Over the past ten years it has ranged from 1.3× (April 2026) to 5.1× (December 2020); the current reading is higher than 33% of that period. That is below the Diagnostics & Research industry median of 3.1× and in line with the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.6× (12.97%)
FY2024 1.8× 2.16%
FY2023 1.7× (27.47%)
FY2022 2.4× (26.26%)
FY2021 3.3× (23.65%)
FY2020 4.3× 12.01%
FY2019 3.8× 13.83%
FY2018 3.4× 3.58%
FY2017 3.2× 20.41%
FY2016 2.7× (5.67%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.7× 25.88%
Mar 2026 1.4× (12.27%)
Dec 2025 1.6× 13.39%
Sep 2025 1.4× (8.82%)
42 more quarters

Against its own ten years

Low 1.3× High 5.1×
Ten-year median 2.8×
Current reading's percentile 36

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
ICLR ICON PLC compare 1.4×
RVTY Revvity Inc. 2.4×
QGEN QIAGEN N.V. compare 2.8×
LH Labcorp Holdings Inc. compare 3.0×
DGX Quest Diagnostics Incorporated compare 3.3×
CRL Charles River Laboratories International, Inc. compare 5.1×
TWST Twist Bioscience Corporation compare 18.6×
MEDP Medpace Holdings, Inc. compare 40.2×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on RVTY